喜讯！上海司太立制药两品种三品规中标二十六省联盟集采

司太立制药2025-06-27

热烈祝贺我司在26省联盟药品集中带量采购中，三品规强势中标，两大明星品种即将放量！碘美普尔注射液和钆贝葡胺注射液成功中标二十六省联盟药品集中带量采购。此次中标展现了公司在产品研发、生产和质量管理方面的实力，以及积极投身国家药品集采政策的决心。上海司太立制药是浙江司太立制药股份有限公司的全资子公司，专注于X射线对比剂的研发和生产。公司将继续坚持“聚合生命能量，呵护人类健康”的经营理念，确保产品质量，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2546503793?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-06-27 13:23","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2546503793","market":"sh","top_or_hot":-1,"title":"喜讯！上海司太立制药两品种三品规中标二十六省联盟集采","media":"司太立制药","content":"<div>\n<p>热烈祝贺我司在26省联盟药品集中带量采购中，三品规强势中标，两大明星品种即将放量！碘美普尔注射液和钆贝葡胺注射液成功中标二十六省联盟药品集中带量采购。此次中标展现了公司在产品研发、生产和质量管理方面的实力，以及积极投身国家药品集采政策的决心。上海司太立制药是浙江司太立制药股份有限公司的全资子公司，专注于X射线对比剂的研发和生产。公司将继续坚持“聚合生命能量，呵护人类健康”的经营理念，确保产品质量，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627132619a72010b7&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>喜讯！上海司太立制药两品种三品规中标二十六省联盟集采</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n喜讯！上海司太立制药两品种三品规中标二十六省联盟集采\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-06-27 13:23 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627132619a72010b7&s=b><strong>司太立制药</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>热烈祝贺我司在26省联盟药品集中带量采购中，三品规强势中标，两大明星品种即将放量！碘美普尔注射液和钆贝葡胺注射液成功中标二十六省联盟药品集中带量采购。此次中标展现了公司在产品研发、生产和质量管理方面的实力，以及积极投身国家药品集采政策的决心。上海司太立制药是浙江司太立制药股份有限公司的全资子公司，专注于X射线对比剂的研发和生产。公司将继续坚持“聚合生命能量，呵护人类健康”的经营理念，确保产品质量，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627132619a72010b7&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"603520","symbol_name":"司太立","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627132619a72010b7&s=b","article_id":"2546503793","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627132619a72010b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2546503793","pubTimestamp":1751001834,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"热烈祝贺我司在26省联盟药品集中带量采购中，三品规强势中标，两大明星品种即将放量！碘美普尔注射液和钆贝葡胺注射液成功中标二十六省联盟药品集中带量采购。此次中标展现了公司在产品研发、生产和质量管理方面的实力，以及积极投身国家药品集采政策的决心。上海司太立制药是浙江司太立制药股份有限公司的全资子公司，专注于X射线对比剂的研发和生产。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"603520":"司太立","BK0239":"医药制造"},"translate_title":"Good news! Shanghai Starry Pharmaceutical won the bid for centralized procurement by 26 provincial alliances with two varieties and three product specifications","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"603520":1},"content_text":"热烈祝贺我司在26省联盟药品集中带量采购中，三品规强势中标，两大明星品种即将放量！碘美普尔注射液和钆贝葡胺注射液成功中标二十六省联盟药品集中带量采购。此次中标展现了公司在产品研发、生产和质量管理方面的实力，以及积极投身国家药品集采政策的决心。上海司太立制药是浙江司太立制药股份有限公司的全资子公司，专注于X射线对比剂的研发和生产。公司将继续坚持“聚合生命能量，呵护人类健康”的经营理念，确保产品质量，丰富产品线，为国内患者提供更多的优质药品。28年深耕造影剂全产业链：司太立制药创立28年，专注造影剂全产业链发展，现为中国碘造影剂原料药知名企业，助力行业高质量发展。碘造影剂品种：公司拥有丰富的碘造影剂产品线，包括碘海醇、碘帕醇等六大主流品种，其中碘美普尔品种为国内首批通过一致性评价的产品。全球布局，国际权威认证：造影剂原料药获欧盟CEP、日本MF、美国DMF等国际权威认证，远销中、日、法等多国；制剂欧盟GMP认证加速推进，深化国际布局，持续提升全球影响力与竞争力。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2546503793","isCrawlerRequest":true}